Expression Profiling of Coding and Noncoding RNAs in the Endometrium of Patients with Endometriosis

• Published in: International journal of molecular sciences 2024-10, Vol.25 (19), p.10581
• Main Authors: Choi, Mi Ran, Chang, Hye Jin, Heo, Jeong-Hyeon, Yum, Sun Hyung, Jo, Eunae, Kim, Miran, Lee, Sang-Rae
• Format: Article
• Language: English
• Subjects: Adult; Angiogenesis; Biomarkers; Cancer; Cell adhesion & migration; Development and progression; Disease; Endometriosis; Endometriosis - genetics; Endometriosis - metabolism; Endometrium; Endometrium - metabolism; Endometrium - pathology; Estrogen; Estrogens; Female; Gene Expression Profiling; Gene Expression Regulation; Genomics; Humans; Instrument industry; long noncoding RNA; menstrual cycle; Menstrual Cycle - genetics; Menstrual Cycle - metabolism; Menstruation; Messenger RNA; MicroRNAs; neighboring gene; RNA, Long Noncoding - genetics; RNA, Messenger - genetics; RNA, Messenger - metabolism; Transcriptome
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms251910581

The aim of this study was to identify differentially expressed lncRNAs (DElncRNAs) and mRNAs (DEmRNAs) in the endometrium of individuals with and without endometriosis (EMS) during the proliferative (P) and secretory (S) phases of the menstrual cycle. Tissues were obtained from 18 control (CT; P-phase [pCT], = 8; S-phase [sCT], = 13) and 23 EMS patients (P-phase [pEMS], = 13; S-phase [sEMS], = 12). DElncRNAs and DEmRNAs were analyzed using total RNA-sequencing. In P-phase, expression of and was significantly higher in EMS than control patients, that of while and was lower in EMS patients. In S-phase, expression of , , and was significantly increased in EMS patients, while that of and was lower. In addition, the expression of , , , and was similar to that of neighboring lncRNAs in both P- and S-phases. In contrast, and , respectively, were up- or downregulated in pEMS tissues. In sEMS, expression of and was increased, while expression of was reduced. Our findings on lncRNAs and mRNAs encourage not only exploration of the potential clinical applications of lncRNAs and mRNAs as prognostic or diagnostic biomarkers for EMS but also to gain valuable insights into its pathogenesis.